Willingness to pay in dermatology: Assessment of the burden of skin diseases

Journal of Investigative Dermatology

Volumn 132, Issue 7, 2012, Pages 1785-1790

  Seidler, Anne M ^a   Bayoumi, Ahmed M ^b,c,d   Goldstein, Mary K ^e,f   Cruz Jr , Ponciano D ^g   Chen, Suephy C ^a,h  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ACTINIC KERATOSIS; ADULT; ARTICLE; BASAL CELL CARCINOMA; CONSTRUCT VALIDITY; CONTACT DERMATITIS; CONTROLLED STUDY; COST OF ILLNESS; DISEASE SEVERITY; ECONOMIC EVALUATION; ECZEMA; EPIDERMOID CYST; FEMALE; HEALTH STATUS; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAID; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SHORT COURSE THERAPY; SKIN DISEASE; VERRUCA VULGARIS; WILLINGNESS TO PAY;

EID: 84862808843     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.50     Document Type: Article

References (14)

1. Bala MV, Mauskopf JA, Wood LL (1999a) Willingness to pay as a measure of health benefits. Pharmacoeconomics 15:9-18 (Pubitemid 29039608)
2. Bala MV, Wood LL, Zarkin GA et al. (1998) Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol 51:667-76 (Pubitemid 28404361)
3. Bala MV, Wood LL, Zarkin GA et al. (1999b) Are health states "timeless"? The case of the standard gamble method. J Clin Epidemiol 52:1047-1053 (Pubitemid 29469807)
4. Bala MV, Zarkin GA (2000) Are QALYs an appropriate measure for valuing morbidity in acute diseases? Health Econ 9:177-80 (Pubitemid 30148164)
5. Chen SC, Bayoumi AM, Soon SL et al. (2004) A catalog of dermatology utilities: a measure of the burden of skin diseases. J Invest Dermatol Symp Proc 9:160-8 (Pubitemid 38457275)
6. Chren MM, Lasek RJ, Flocke SA et al. (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133:1433-40 (Pubitemid 27490569)
7. Drummond MF, Jefferson TO (1996) Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. Br Med J 313:275-83 (Pubitemid 26254740)
8. Franic DM, Pathak DS, Gafni A (2005) Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey. J Clin Epidemiol 58:291-303 (Pubitemid 40249473)
9. Goddeeris JH (1983) Theoretical considerations on the cost of illness. J Health Econ 2:149-59
10. Goldstein MK, Tsevat J (2003) Assessing desirability of outcome states for medical decision making and cost-effectiveness analysis. In: Max MB, Lynn J (eds) Symptom Research: Methods and Opportunities Chapter 24, National Institutes of Health: (http://painconsortium.nih.gov/symptomresearch/chapter-24/ sec3/cmgs3pg1.htm)
11. Landefeld JS, Seskin EP (1982) The economic value of life: linking theory to practice. Am J Public Health 72:555-66
12. Lundberg L, Johannesson M, Silverdahl M et al. (1999) Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 141:1067-75 (Pubitemid 30046197)
13. Olsen JA, Smith RD (2001) Theory versus practice: a review of "willingness-to-pay" in health and health care. Health Econ 10:39-52
14. Thompson MS (1986) Willingness to pay and accept risks to cure chronic disease. Am J Public Health 76:392-6